ArticlePharmacological reports : PR2025

Early plasma changes of HIF-1 alpha, matrix metalloproteinases-2 and - 9, and tissue inhibitor of matrix metalloproteinase-1 in patients with infantile hemangiomas treated with propranolol.

Małgorzata Kowalska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.